Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
MYSZ vs MYO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MYO Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–2 Matrix Metrics)
MYO Overall Winner
6-Pillar Tally: MYSZ 1 – 4 MYO (1 Tie)
Matrix Metrics: MYSZ 2 – 6 MYO
As of Nov 20, 2026, Myomo Inc. (MYO) is the stronger overall head-to-head candidate over My Size, Inc (MYSZ) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MYSZ carries a Unified Composite Score of 56.6/100 (HOLD) at $0.87 (N/M Forward P/E, -71.6% operating margin), whereas MYO carries 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin).
- Composite vs. Pillar Nuance: While MYSZ currently prints a higher short-term Unified Composite Score (56.6/100 HOLD vs. MYO 40.1/100 SELL), MYO captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-21.8% vs. -71.6% operating margin) and revenue trajectory (+22.2% vs. -27.8% YoY).
- Technical & Structure Timing Caution: MYSZ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.8); meanwhile MYO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About MYSZ vs MYO
MYSZ
My Size, Inc
$0.87
+22.51% 1D
Market Cap
$838,691
TTM Revenue
$11M
Forward P/E
N/M
Beta / 30D Vol
3.20β · 116% Vol
Unified Composite Score
56.6
HOLD
Tech 68.0
Fund 60.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
MYO
Head-to-Head Winner
Myomo Inc.
$0.81
-3.45% 1D
Market Cap
$33.7M
TTM Revenue
$46M
Forward P/E
N/M
Beta / 30D Vol
2.22β · 107% Vol
Unified Composite Score
40.1
SELL
Tech 25.0
Fund 43.0
Flow 58.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (MYSZ 1 – 4 MYO)
1. Valuation Multiples
MYSZ
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
0.1x
0.9x
2. Growth & Scale
MYO
Revenue Growth (YoY)
-27.8%
+22.2%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$11M
$46M
Market Cap
$838,691
$33.7M
3. Profitability & Quality
MYO
Gross Margin
27.8%
70.1%
Operating Margin
-71.6%
-21.8%
Net Profit Margin
-75.6%
-33.1%
Return on Equity (ROE)
-150.6%
-173.5%
4. Balance Sheet & Cash Flow
MYO
Cash Generation (TTM)
-$7.1M EBITDA
-$9.1M
Cash Flow Margin
-66.5% EBITDA Mgn
-20.0%
Net Cash / Leverage
$625,000 Net Debt (0.32x D/E)
$8.9M Net Debt (3.44x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
MYO
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
266.0% (81st %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Apparel Retail Operator
Medical Devices Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: MYSZ (2) vs MYO (6)| Institutional Metric | MYSZ | MYO | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $838,691 | $33.7M | MYO | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | -27.8% | +22.2% | MYO | |
| Operating Margin (TTM) | -71.6% | -21.8% | MYO | |
| Net Profit Margin | -75.6% | -33.1% | MYO | |
| Return on Equity (ROE) | -150.6% | -173.5% | MYSZ | |
| 52-Week Range Position | 14% ($0–$4) | 16% ($1–$2) | MYO | |
| Beta / 30D Volatility | 3.20β · 116% Vol | 2.22β · 107% Vol | MYO | |
| Unified Institutional Score | 56.6 / 100 (HOLD) | 40.1 / 100 (SELL) | MYSZ | |
| Trailing 12M Revenue (USD) | $11M | $46M | Scale | |
| Gross Profit Margin (TTM) | 27.8% | 70.1% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 0.1x EV/Rev | N/M PEG · 0.9x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$7.1M EBITDA ($625,000 Net Debt (0.32x D/E)) | -$9.1M ($8.9M Net Debt (3.44x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
MYSZ +17.15 pp
3M Horizon
MYO +24.9 pp
6M Horizon
MYSZ +99.53 pp
1Y Horizon
MYO +8.36 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MYSZ Revenue | MYO Revenue | MYSZ Op. Margin | MYO Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -430.8% | MYO |
| FY2019 | $0M | $0M | -9507.9% | -281.3% | MYO |
| FY2020 | $0M | $10M | -4328.2% | -138.5% | MYO |
| FY2021 | $0M | $10M | -8074.0% | -74.1% | MYO |
| FY2022 | $0M | $20M | -181.9% | -68.6% | MYO |
| FY2023 | $10M | $20M | -96.4% | -42.8% | MYO |
| FY2024 | $10M | $30M | -47.8% | -19.1% | MYO |
| FY2025 | $10M | $40M | -61.3% | -35.2% | MYO |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
MYSZ
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact MYSZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
MYO
UNCLASSIFIED
Current IV
266.0%
IV Percentile
81st %ile
Put/Call OI Skew
N/A
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact MYO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
MYSZ Moat Profile
Cyclical / Execution-Driven Positioning
Apparel Retail Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
MYO Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ MYSZ vs MYO Key Questions & Quantitative Answers
As of Nov 20, 2026, Myomo Inc. (MYO) is the stronger overall head-to-head candidate over My Size, Inc (MYSZ) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MYSZ carries a Unified Composite Score of 56.6/100 (HOLD) at $0.87 (N/M Forward P/E, -71.6% operating margin), whereas MYO carries 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin). Composite vs. Pillar Nuance: While MYSZ currently prints a higher short-term Unified Composite Score (56.6/100 HOLD vs. MYO 40.1/100 SELL), MYO captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-21.8% vs. -71.6% operating margin) and revenue trajectory (+22.2% vs. -27.8% YoY). Technical & Structure Timing Caution: MYSZ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.8); meanwhile MYO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MYO leads the Growth & Scale pillar: MYSZ posts -27.8% YoY revenue growth and +0.0% YoY earnings growth on $11M TTM revenue (27.8% gross margin, -71.6% operating margin), compared with MYO at +22.2% YoY revenue growth and +0.0% YoY earnings growth on $46M TTM revenue (70.1% gross margin, -21.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), MYSZ cumulative revenue shifted +0.0% while MYO shifted +300.0%. In operating R&D and SG&A reinvestment, MYSZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MYO.
MYSZ screens cheaper on headline valuation multiples. MYSZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-66.5% EBITDA margin), whereas MYO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-20.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MYSZ (-150.6% ROE) versus MYO (-173.5% ROE) capital efficiency.
In options market volatility and institutional positioning, MYSZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.20β · 116% Vol realized risk). By comparison, MYO carries 266.0% implied volatility (81st %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.22β · 107% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
MYO vs MYSZ · Reverse Pair
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal